Literature DB >> 10125812

The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe.

K Tolley1, M Gyldmark.   

Abstract

A number of European studies have attempted to assess the treatment and care costs of people with HIV infection or AIDS. However, because of the different methods used, the various cost estimates produced are difficult to compare. This paper reviews several European HIV-AIDS costs studies and outlines the differences in methods used and where better approaches to cost estimation could have been adopted. The application of a standardised cost framework to new cost studies would improve the basis for making cost comparisons of models of care in different sites and countries and the identification of actual (rather than methodological) variations in costs across sites. The final part of the paper provides a discussion of the development and application of a standardised framework for assessment of the costs of HIV-AIDS treatment and care in Europe.

Entities:  

Mesh:

Year:  1993        PMID: 10125812     DOI: 10.1016/0168-8510(93)90088-7

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  11 in total

Review 1.  Health economics in HIV disease. A review of the European literature.

Authors:  M Youle; P Trueman; K Simpson
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 2.  The impact of disease stage on direct medical costs of HIV management: a review of the international literature.

Authors:  Adrian Levy; Karissa Johnston; Lieven Annemans; Andrea Tramarin; Julio Montaner
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.

Authors:  Caroline E Sloan; Karen Champenois; Philippe Choisy; Elena Losina; Rochelle P Walensky; Bruce R Schackman; Faiza Ajana; Hugues Melliez; A D Paltiel; Kenneth A Freedberg; Yazdan Yazdanpanah
Journal:  AIDS       Date:  2012-01-02       Impact factor: 4.177

4.  Hospital care for persons with AIDS in European-Union countries; a cross-country comparison.

Authors:  M J Postma; H Kornarou; V Paparizos; R M Leidl; K Tolley; J Kyriopoulos; J C Jager
Journal:  Health Care Manag Sci       Date:  2000-01

5.  The economic costs of caring for people with HIV infection and AIDS in England and Wales.

Authors:  S Petrou; M Dooley; L Whitaker; E Beck; E Kupek; J Wadsworth; D Miller; A Renton
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

Review 6.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

7.  Average annual drug cost and its determinants in a population based cohort of HIV-positive adult men and women.

Authors:  A H Anis; R S Hogg; B Yip; X H Wang; J S Montaner; M V O'Shaughnessy; M T Schechter
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981

8.  Use and cost of antiretrovirals in France 1995-2000: an analysis based on the Medical Dossier on Human Immunodeficiency (release 2) database.

Authors:  Yves A Flori; Marc le Vaillant
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.

Authors:  Hartmut B Krentz; M Christopher Auld; M John Gill
Journal:  CMAJ       Date:  2003-07-22       Impact factor: 8.262

10.  Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008.

Authors:  Eduard J Beck; Sundhiya Mandalia; Roshni Sangha; Mike Youle; Ray Brettle; Mark Gompels; Margaret Johnson; Anton Pozniak; Achim Schwenk; Stephen Taylor; John Walsh; Ed Wilkins; Ian Williams; Brian Gazzard
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.